CHAIR
:
SPEAKER
(S):
Yong Soo Bae, PhD, CEO , CreaGene Inc.
Sung Ho Han, PhD, Director , Medipost
Ho Won Kim, Deputy Minister, Ministry of Commerce, Industry and Energe Republic of Korea
Kwan Lee, PhD, CTO , Kolon Life Science
Description
The main subjects on Korea session are as follows; the current status of advanced Korea biotechnology, momentum of Korean Cell Therapy technology and successful investment cases in Korea.
Objective1:Provide an understanding of current Korea Cell therapy.
Objective2:Introduce Korea Cell therapy technlogy R&D successful results in the past 10 years.
Objective3:Suggest opportunities for collaborative relationships with Korea.